INFO:

The time it takes for a novel cancer therapy to go from investigational new drug application to FDA approval is typically longer than a decade. “There has to be a better way,” says Bob T. Li, MD, PhD, MPH. He and Robert A. Figlin, MD, discuss the pros and cons of a more global approach to cancer drug development.